Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 87 clinical trials
A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)

Multi-center, randomized, double-blind, vehicle-controlled, parallel group, multi-dose escalation study of TDM-105795 in male subjects, 18 to 55 years old, with Androgenetic Alopecia (AGA).

Accepts healthy volunteers
androgenic alopecia
  • 0 views
  • 17 May, 2022
  • 2 locations
Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata (AA)

scalp hair loss. The study is placebo-controlled, meaning that some patients entering the study will not receive active study drug but will receive tablets with no active ingredients (a placebo). It is

areata alopecia
  • 0 views
  • 28 May, 2022
  • 1 location
Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata

The purpose of this study is to assess the preliminary efficacy, safety, tolerability, PK, and PD of Daxdilimab in participants with moderate to severe AA, with ≥50% and ≤95% total scalp hair

  • 0 views
  • 27 May, 2022
  • 3 locations
Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic Alopecia

Androgenetic alopecia (AGA) is hair loss with specific clinical pattern, It Is characterized by follicular miniaturization, which occurs due to systemic androgens and genetic factors. Prevalence

Accepts healthy volunteers
  • 0 views
  • 27 May, 2022
  • 1 location
Cold Plasma to Treat Hair Loss

Self applied cold plasma activated medium used for androgenetic alopecia

alopecia
cold
androgenic alopecia
  • 1272 views
  • 23 Apr, 2022
  • 1 location
Low Level Light Therapy (LLLT) for Hair Growth

A total of 62 participants will receive red light (660 nm) to the scalp through a specially designed light therapy device integrated into a conventional hat. Each treatment will be 30 min per session applied on every other day for 14 weeks.

photobiomodulation therapy
alopecia
Accepts healthy volunteers
ludwig
low-level laser therapy
  • 1173 views
  • 07 Feb, 2022
  • 1 location
A Study to Evaluate the Efficacy and Safety of AD-208

The purpose of this study is to evaluate the efficacy and safety of AD-208.

  • 0 views
  • 23 Nov, 2021
  • 1 location
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata (AZURE)

Efficacy and safety of rosnilimab (ANB030) in subjects with moderate-to-severe Alopecia Areata

areata alopecia
  • 0 views
  • 23 May, 2022
  • 15 locations
Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair

The objective of this study is to assess the effectiveness and safety of a novel dietary supplement containing botanical ingredients for hair thinning in men over the course of six months of

Accepts healthy volunteers
  • 0 views
  • 06 May, 2022
  • 1 location
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata

makes a mistake and attacks the body. Some people with APECED have a type of hair loss called alopecia areata (AA). No drugs are approved to treat AA. Objective To

graft-versus-host disease
cervical cap
bilateral tubal ligation
blood tests
ruxolitinib
  • 20 views
  • 17 Jun, 2022
  • 1 location